Levcromakalim

HCID 93504CAS 94470-67-4

Grundinformationen

Standard-SMILES
CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O
InChIKey
TVZCRIROJQEVOT-CABCVRRESA-N
Summenformel
C16H18N2O3
Durchschnittliche Molmasse
286,33 g/mol
Monoisotopische Masse
286,13174244

Namen und Bezeichner

Bevorzugter Name
Levcromakalim
IUPAC
(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile
Englischer Name
LEVCROMAKALIM
Summenformel
C16H18N2O3
Molmasse
286.33

Namen und Synonyme

Levcromakalim94535-50-9(-)-CromakalimBRL-38227DTXSID5045677RW7PN4BLDJ2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, (3S,trans)-(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)chromane-6-carbonitrileDTXCID3025677levcromakalimumBRL38227RefChem:924700
Weitere Namen anzeigen
Brn 3622889levcromakelimLevkroMakaliM(3s-trans)-yrrolidinyl)Levcromakalim, 10 mM in DMSOLevcromakalim, KATP channel activatorPotassium Channel,KcsA,Inhibitor,inhibit,BRL38227,BRL-38227,Levcromakalim
LemakalimBRL 38227BRL 34915CHEMBL100MLS000069770(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6-chromancarbonitrile(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile(+/-)-cromakalim

Datenbank-Bezeichner

CAS
94470-67-4、94535-50-9
PubChem CID
93504
DTXSID
DTXSID5045677
ChEMBL
CHEMBL100、CHEMBL11684
ChEBI
CHEBI:6436
UNII
0G4X367WA3、RW7PN4BLDJ
Nikkaji
J257.580I

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,8
Polarare Oberfläche (TPSA)
73,6 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
21

Physikochemische Eigenschaften

Schmelzpunkt
242 · 242-244°
Siedepunkt
482.3 · 482.3±45.0 °C(Predicted)
Dichte
1.31 · 1.31±0.1 g/cm3(Predicted)
storage temp.
Store at RT
Löslichkeit
10 mM, · DMSO: ≤10 mM, soluble
Aggregatzustand
solid

Sicherheit und Regulatorisches

Sicherheitsdaten

wgk
3
RTECS-Nr.
DJ2177500
safety_code
22-24/25

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 4 Einträge

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

Drugs used to cause dilation of the blood vessels.

Anwendungen

VerwendenLevcromakalim is a potassium channel activator and vasorelaxant used in the management of hypertension in diabetes mellitus.

Anbieter29 Anbieter

成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
Aladdin Scientific[email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]

Zugehörige Reaktionen

8

Verknüpfte Notizen

Wird geladen…